HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yeon-Sun Seong Selected Research

AT 7867

3/2021Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yeon-Sun Seong Research Topics

Disease

14Neoplasms (Cancer)
12/2021 - 09/2006
11Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2012
6Triple Negative Breast Neoplasms
06/2021 - 05/2013
5Adenocarcinoma
01/2021 - 01/2012
2Leukemia
03/2021 - 05/2013
2Breast Neoplasms (Breast Cancer)
07/2015 - 12/2014
1Sarcoma (Soft Tissue Sarcoma)
03/2021
1Thymoma (Thymic Carcinoma)
03/2021
1Ovarian Neoplasms (Ovarian Cancer)
07/2015
1Glioma (Gliomas)
12/2012
1Prostatic Neoplasms (Prostate Cancer)
12/2012
1Testicular Neoplasms (Testicular Cancer)
12/2007
1Stomach Neoplasms (Stomach Cancer)
09/2006

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
03/2018 - 09/2006
9GemcitabineFDA Link
01/2021 - 01/2012
6Protein Kinase InhibitorsIBA
03/2021 - 03/2012
44,4',5'-trimethylazapsoralenIBA
06/2009 - 09/2006
3ErbB Receptors (EGF Receptor)IBA
06/2021 - 05/2013
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
06/2009 - 05/2007
2Biomarkers (Surrogate Marker)IBA
12/2021 - 07/2017
2Ribosomal Protein S6IBA
12/2021 - 07/2015
2Gefitinib (Iressa)FDA Link
03/2021 - 05/2013
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 12/2012
2Pharmaceutical PreparationsIBA
12/2014 - 03/2012
2Aldehyde DehydrogenaseIBA
06/2014 - 09/2012
1Mechanistic Target of Rapamycin Complex 1IBA
12/2021
1Therapeutic UsesIBA
06/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2021
1Drug CombinationsIBA
03/2021
1AT 7867IBA
03/2021
1Trypan BlueFDA Link
01/2021
1Doxycycline (Periostat)FDA LinkGeneric
01/2021
1Anaplastic Lymphoma KinaseIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
03/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2018
1Aldehyde Dehydrogenase 1 FamilyIBA
07/2017
1Fluorouracil (Carac)FDA LinkGeneric
07/2017
1bovine corneal protein 54 (aldehyde dehydrogenase 3)IBA
07/2017
1Glutamate-Cysteine LigaseIBA
07/2017
1Poly(ADP-ribose) Polymerase InhibitorsIBA
07/2015
1olaparibIBA
07/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2015
1dactolisibIBA
07/2015
1MTOR InhibitorsIBA
02/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014
1ParaquatIBA
12/2014
1Dasatinib (BMS 354825)FDA Link
06/2014
1PIK 75IBA
03/2014
1Proteasome Endopeptidase Complex (Proteasome)IBA
03/2014
1Checkpoint Kinase 2IBA
10/2013
1diacetyldiphenylurea bisguanylhydrazone (DDUG)IBA
10/2013
1PI103IBA
05/2013
1Phosphotransferases (Kinase)IBA
05/2013
1BML-275IBA
12/2012
16- (2- tert- butyl- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 4- yl)quinoxalineIBA
03/2012
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
03/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2012
1Transforming Growth Factor-beta Type I ReceptorIBA
03/2012
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2012
1ZSTK474IBA
01/2012
1AntigensIBA
12/2007
1ChromatinIBA
12/2007

Therapy/Procedure

2Drug Therapy (Chemotherapy)
06/2014 - 09/2012
1Therapeutics
10/2013